Johnson & Johnson and Boston Scientific have also recently made moves to sell their own coronary intravascular lithotripsy ...
Zacks Investment Research on MSN1d
Fed's Stagflation Fears Weigh, Yet Growth Factors Make BSX Stock a BuyBoston Scientific BSX is experiencing a temporary cooling-off period after its strong run in 2024, where the stock climbed 54.5%, banking on robust financial performance and product advancements ...
According to Research by SNS Insider, The Pulsed Field Ablation Market Growth is Driven by Technological Advancements and Rising Prevalence of Atrial FibrillationPune, March 20, 2025 (GLOBE NEWSWIRE) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback